Sector Chart Vertex Pharmaceuticals Incorporated Sao Paulo
Stocks
VRTX34
BRVRTXBDR001
Pharmaceuticals
|
Delayed
Sao Paulo
15:29:53 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 85.86 BRL | -0.42% |
|
+3.90% | +9.74% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,056B | |||||
| 645B | - | ||||
| 465B | |||||
| 368B | |||||
| 335B |
Select your edition
All financial news and data tailored to specific country editions
